Teratogenicity Associated With Pre-Existing and Gestational Diabete

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 11, 2007, Pages 927-934

  Allen, Victoria M ^a   Armson, B Anthony ^a   Wilson, R Douglas ^a   Blight, Claire ^a   Gagnon, Alain ^a   Johnson, Jo Ann ^a   Langlois, Sylvie ^a   Summers, Anne ^a   Wyatt, Philip ^a   Farine, Dan ^a   Crane, Joan ^a   Delisle, Marie France ^a   Keenan Lindsay, Lisa ^a   Morin, Valerie ^a   Schneider, Carol Ellison ^a   Van Aerde, John ^a  

^a NONE   (Canada)

Author keywords

BMI; Congenital anomalies; Diabetes mellitus; Gestational diabetes; GU; HbA1c; PAPP A; Pre existing diabetes; HCG

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; FOLIC ACID; GLIBENCLAMIDE; INSULIN GLARGINE; MEGLITINIDE; METFORMIN;

AMBIGUOUS GENITALIA; ANEUPLOIDY; ANUS ATRESIA; AORTA COARCTATION; ARNOLD CHIARI MALFORMATION; ARTICLE; AWARENESS; CARDIOMEGALY; CAUDAL DYSGENESIS; CLEFT PALATE; CLUBFOOT; CONGENITAL MALFORMATION; CONTRACTURE; CORPUS CALLOSUM AGENESIS; COSTOVERTEBRAL ANOMALY; COUNSELING; CRANIOFACIAL SYNOSTOSIS; CRYPTORCHISM; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DUODENUM ATRESIA; FALLOT TETRALOGY; FETUS DISEASE; GLYCEMIC CONTROL; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HERNIA; HOLOPROSENCEPHALY; HUMAN; HYDRONEPHROSIS; HYPOPLASTIC LEFT HEART SYNDROME; HYPOPLASTIC TESTES; HYPOPLASTIC VAGINA; HYPOSPADIAS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY AGENESIS; KIDNEY CYST; LIMB REDUCTION DEFECT; MACROCEPHALY; MICROCEPHALY; MICROCOLON; MICROPENIS; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OLFACTORY TRACT AGENESIS; OMPHALOENTERIC CYST; PATHOPHYSIOLOGY; POLYSYNDACTYLY; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; PYLORUS STENOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZENCEPHALY; SINGLE UMBILICAL ARTERY; SYSTEMATIC REVIEW; TERATOGENESIS; TERATOGENICITY; URETER DUPLICATION; URETEROCELE; UTERINE AGENESIS; CONGENITAL DISORDER; FEMALE; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE;

CONGENITAL ABNORMALITIES; COUNSELING; DIABETES, GESTATIONAL; FEMALE; FETAL DISEASES; FOLIC ACID; HUMANS; OBESITY; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 38649086116     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32653-6     Document Type: Article

References (62)

1. Health Canada Canadian Perinatal Health Report, Congenital Anomalies in Canada 2002, Minister of Public Works and Government Services Canada, Ottawa.
2. Eriksson U.J., Cederberg J., Wentzel P. Congenital malformations in offspring of diabetic mothers- animal and human studies. Rev Endocrinol Metabol Dis 2003, 4:79-93.
3. Wilson R.D. Principles of human teratology: drug, chemical, and infectious exposure. SOGC Clinical Practice Guidelines, No. 199, November 2007. J Obstet Gynaecol Can 2007, 29:911-917.
4. Woolf S.H., Battista R.N., Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2003, 169(3):207-208.
5. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42.
6. Kousseff B.G. Diabetic embryopathy. Curr Opin Pediatr 1999, 11:348.
7. Zaw W., Stone D.G. Caudal regression syndrome in twin pregnancy with type II diabetes. J Perinatol 2002, 2:171-174.
8. Smoak I.W. Hypoglycemia and embryonic heart development. Front Biosci 2002, 7:d307-d318.
9. Savion S., Gidon-Dabush S., Fein A., Torchinsky A., Toder V. Diabetes teratogenicity is accompanied by alterations in macrophages and T cell subpopulations in the uterus and lymphoid organs. Int Immunopharmacol 2004, 4:1319-1327.
10. Lian Q., Thameem Dheen S., Liao D., Sam Wah Tay S. Enhanced inflammatory response in neural tubes of embryos derived from diabetic mice exposed to a teratogen. J Neuroscience Res 2004, 75:554-564.
11. Punareewattana K., Sharova L.V., Li W., Ward D.L., Holladay S.D. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice. Int Immunopharmacol 2003, 3:1639-1655.
12. Meltzer S.J., Ryan E.A., Feig D.S., Thompson D., Snyder J. Preconception care for women with diabetes 2003, Canadian Diabetes Association, Clinical Practice Guidelines.
13. Aberg A., Westbom L., Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or pre-existing diabetes. Early Human Develop 2001, 61:85-95.
14. Martinez-Frias M.L., Bermejo E., Rodriguez-Pinilla Prieto L., Frias J.L. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genetics 1998, 78:140-145.
15. Sheffield J.S., Butler-Koster Casey B.M., McIntire D.D., Leveno K.J. Maternal diabetes and infant malformations. Obstet Gynecol 2002, 100:925-930.
16. Sharpe P.B., Chan A., Haan E.A., Hiller J.E. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Defects Res 2005, 73:605-611.
17. Martinez-Frias M.L., Rodriguez-Pinilla E.S., Bermejo E.Prieto Epidemiological evidence that maternal diabetes does not appear to increase the risk for Down syndrome. Am J Med Genetics 2002, 112:335-337.
18. Towner D., Kjos S.L., Leung B., Montoro M.M., Xiang A., Mestman J.H., Buchanan T.A. Congenital malformations in pregnancies complicated by NIDDM. Increase risk from poor maternal metabolic control but not from exposure to sulfonylurea drugs. Diabetes Care 1995, 18:1446-1451.
19. Casson I.F., Clarke C.A., Howard C.V., McKendrick O., Pennycook S., Pharoah P.O.D., Platt M.J., Stanisstreet M., van Velszen D., Walkinshaw S. Outcomes of pregnancy in insulin dependent diabetic women: results of a five-year population cohort study. BMJ 1997, 315:275-278.
20. Evers I.M., de Valk H.W., Visser G.H.A. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004, 328:915-919.
21. Jensen D.M., Damm P., Moelsted-Pedersen L., Ovesen P., Westergaard J.G., Moeller M., et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004, 27:2819-2823.
22. Dunne F.P., Brydon P.A., Proffitt M., Sith T., Gee H., Holder R.L. Fetal and maternal outcomes in Indo-Asian compared to Caucasian women with diabetes in pregnancy. Q J Med 2000, 93:813-818.
23. Kitzmiller J.L., Gavin L.A., Gin G.D., Jovanovic-Peterson L., Main E.K., Zigrang W.D. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 1991, 265:731-736.
24. Langer O., Conway D.L. Level of glycemia and perinatal outcome in pregestational diabetes. J Mat Fet Med 2000, 9:35-41.
25. American Diabetes Association Gestational diabetes mellitus. Diabetes Care 2000, 23:S77-S79.
26. Temple R., Aldridge V., Greenwood R., Heyburn P., Sampson M., Stanley K. Association between outcome of pregnancy in type 1 diabetes: population based study. BMJ 2002, 325:1275-1276.
27. The Diabetes Control Complications Trial Research Group Pregnancy outcomes in the Diabetes Control and Complications trial. Am J Obstet Gynecol 1996, 174:1343-1353.
28. Schaefer-Graf U.M., Buchanan T.A., Xiang A., Songster G., Montoro M., Kjos S.L. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by Type 2 and gestational diabetes. Am J Obstet Gynecol 2000, 182:313-320.
29. Suhonen L., Hiilesmaa V., Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 2000, 43:79-82.
30. Hanson U., Persson B., Thunell S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990, 33:100-104.
31. Farrell T., Neale L., Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002, 19:322-326.
32. McElduff A., Cheung N.W., McIntyre H.D., Lagstom J.A., Oats J.J.N., Ross G.P., et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. MJA 2005, 183:373-377.
33. Naylor C.D., Sermer M., Chen E., Sykora K. Cesarean delivery in relation to birth weight and gestational glucose intolerance: pathophysiology or practice style? Toronto Tri-Hospital Gestational Diabetes Investigators. JAMA 1996, 275:1165-1170.
34. Kousseff B.G. Gestational diabetes mellitus (Class A): a human teratogen?. Am J Med Gen 1999, 83:402-408.
35. Versiani B.R., Gilbert-Barness E., Giuliani L.R., Peres L.C., Pina-Neto J.M. Caudal dysplasia sequence: severe phenotype presenting in offspring of patients with gestational and pregestational diabetes. Clin Dysmorphol 2004, 13:1-5.
36. American Diabetes Association Gestational diabetes mellitus. Diabetes Care 2005, 25:S82-S84.
37. Berger H., Crane J., Farine D., Armson B.A., de la Ronde S., Keenan-Lindsay L., Leduc L., et al. Screening for gestational diabetes. J Obstet Gynaecol Can 2002, 24:894-903.
38. Merlob P., Levitt O., Stahl B. Oral antihyperglycemic agents during pregnancy and lactation: a review. Paediatr Drugs 2002, 4:755-760.
39. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003, 298:76-79.
40. Dolci M., Mori M., Baccetti F. Use of glargine insulin before and during pregnancy in a woman with type I diabetes and Addison's disease. Diabetes Care 2005, 28:2084-2085.
41. Di Cianni G., Volpe L., Lencioni C., Chatzianagnostou K., Cuccuru I., Ghio A., et al. Use of insulin glargine during the first weeks of pregnancy in five type I diabetic women. Diabetes Care 2005, 28:982-983.
42. Woolderink J.M., van Loon A.J., Storms F., de Heide L., Hoogenberg K. Use of insulin glargine during pregnancy in seven type I diabetic women. Diabetes Care 2005, 28:2594-2595.
43. Watkins M.L., Rasmussen S.A., Honein M.A., Botto L.D., Moore C.A. Maternal obesity and risk of birth defects. Pediatr 2003, 111:1152-1158.
44. Hofmann T., Horstmann G., Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol 2002, 21:181-189.
45. Shaw G.M., Velie E.M., Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996, 275:1093-1096.
46. Cedergren M.L., Kallen B.A.J. Maternal obesity and infant heart defects. Obes Res 2003, 11:1065-1071.
47. Anderson J.L., Waller D.K., Canfield M.A., Shaw G.M., Watkins M.L., Werler M.M. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiol 2005, 16:87-92.
48. Moore L.L., Singer M.R., Bradlee M.L., Rothman K.J., Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiol 2000, 11:689-694.
49. Martinez-Frias M.L., Frias J.P., Bermejo E., Rodriguez-Pinilla E., Prieto L., Frias J.L. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes. Diabet Med 2005, 22:775-781.
50. Huttly W., Rudnicka A., Wald N.J. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Prenat Diagn 2004, 24:804-807.
51. American Diabetes Association Preconception care of women with diabetes. Diabetes Care 2004, 27:S76-S78.
52. Holing E.V., Shaw Beyer C., Brown Z.A., Connell F.A. Why don't women with diabetes plan their pregnancies?. Diabetes Care 1998, 21:889-895.
53. Steel J.M., Johnstone F.D., Hepburn D.A., Smith A.F. Can pre-pregnancy care of diabetic women reduce the risk of abnormal babies?. BMJ 1990, 30:1070-1077.
54. Ray J.G., O'Brien T.E., Chan W.S. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001, 94:435-444.
55. McElvy S.S., Miodovnik M., Rosenn B., Khoury J.C., Siddiqi T., Dignan P.S.J., et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000, 9:14-20.
56. Diabetes and Pregnancy Group, France French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003, 26:2990-2993.
57. Willhoite M.B., Bennert H.W., Palomaki G.E., Zaremba M.M., Herman W.H., Williams J.R., et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993, 16:450-455.
58. Miodovnik M., Mimouni F., Dignan P.S.J., Berk M.A., Ballard J.L., Siddiqi T.A., et al. Major malformations in infants of IDDM women. Vasculopathy and early first-trimester poor glycemic control. Diabetes Care 1988, 11:713-718.
59. Dunne F.P., Chowdhury T.A., Hartland A., Smith T., Brydon P.A., McConkey C., et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. Q J Med 1999, 92:451-454.
60. Hadden D.R., Alexander A., McCance D.R., Traub A.I. Northern Ireland Diabetes Group and the Ulster Obstetrical Society. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabetic Med 2001, 18:546-553.
61. Schaefer U.M., Songster G., Xiang A., Berkowitz Buchanan T.A., Kjos S.L. Congenital malformations in offspring of women with hyperglycemia first detected in pregnancy. Am J Obstet Gynecol 1997, 177:1165.
62. Wilson R.D., Davies G., Desiliets V., Reid G.J., Summers A., Wyatt P., et al. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003, 138:959-965.